Safety and Efficacy of Andecaliximab (GS-5745) in Adults With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT02520284 · TERMINATED
Trial details
- NCT number
- NCT02520284
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-09-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.